117 related articles for article (PubMed ID: 22648769)
1. Vector systems for prenatal gene therapy: principles of retrovirus vector design and production.
Howe SJ; Chandrashekran A
Methods Mol Biol; 2012; 891():85-107. PubMed ID: 22648769
[TBL] [Abstract][Full Text] [Related]
2. Vector systems for prenatal gene therapy: principles of adenovirus design and production.
Alba R; Baker AH; Nicklin SA
Methods Mol Biol; 2012; 891():55-84. PubMed ID: 22648768
[TBL] [Abstract][Full Text] [Related]
3. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
4. Vector systems for prenatal gene therapy: principles of non-viral vector design and production.
Wong SP; Argyros O; Harbottle RP
Methods Mol Biol; 2012; 891():133-67. PubMed ID: 22648771
[TBL] [Abstract][Full Text] [Related]
5. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
6. Vector systems for prenatal gene therapy: choosing vectors for different applications.
Coutelle C; Waddington SN
Methods Mol Biol; 2012; 891():41-53. PubMed ID: 22648767
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
[TBL] [Abstract][Full Text] [Related]
9. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
11. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
12. Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze.
Behrens A; Gordon EM; Li L; Liu PX; Chen Z; Peng H; La Bree L; Anderson WF; Hall FL; McDonnell PJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):968-77. PubMed ID: 11923236
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vector targeting for gene therapy.
Günzburg WH; Fleuchaus A; Saller R; Salmons B
Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
[TBL] [Abstract][Full Text] [Related]
14. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
15. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
Makarov SS; Olsen JC; Johnston WN; Schwab JH; Anderle SK; Brown RR; Haskill JS
Gene Ther; 1995 Aug; 2(6):424-8. PubMed ID: 7584118
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector production in the National Gene Vector Laboratory at Indiana University.
Cornetta K; Matheson L; Ballas C
Gene Ther; 2005 Oct; 12 Suppl 1():S28-35. PubMed ID: 16231053
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences.
Kondo E; Akatsuka Y; Nawa A; Kuzushima K; Tsujimura K; Tanimoto M; Kodera Y; Morishima Y; Kuzuya K; Takahashi T
Gene Ther; 2005 Feb; 12(3):252-8. PubMed ID: 15496958
[TBL] [Abstract][Full Text] [Related]
19. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
20. Cell line issues related to specific expression vectors: retrovirus vectors.
Morgan EM
Dev Biol Stand; 1992; 76():301-5. PubMed ID: 1478348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
